Neumora Therapeutics (NMRA) Return on Capital Employed [ROCE] (2023 - 2026)
Neumora Therapeutics' Return on Capital Employed [ROCE] was -188.96% in Q2 2026, down 68.24 percentage points from -120.72% a year earlier and down 32.24 percentage points from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Neumora Therapeutics came in at -108.85%, down 38.90 percentage points from FY2024.
- In earlier years, Return on Capital Employed [ROCE] was -69.94% in FY2024 (-12.13 pp) and -57.81% in FY2023.
- The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2023.
- Compared with a year earlier, Return on Capital Employed [ROCE] has declined for seven straight quarters, with an average year-over-year change of -52.76 percentage points over the last seven quarters.
- Per Business Quant data, NMRA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -156.72% (Q1 2026), -158.67% (Q4 2025) and -140.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.76% |
| 10 | Neumora Therapeutics | 112.74 Mn | 112.74 Mn | - | -188.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -188.96% |
| Mar 31, 2026 | -156.72% |
| Dec 31, 2025 | -158.67% |
| Sep 30, 2025 | -140.35% |
| Jun 30, 2025 | -120.72% |
| Mar 31, 2025 | -106.13% |
| Dec 31, 2024 | -86.42% |
| Sep 30, 2024 | -90.71% |
| Jun 30, 2024 | -72.92% |
| Mar 31, 2024 | -60.86% |
| Dec 31, 2023 | -50.89% |
API Access
Neumora Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();